News

Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
NICE recommends cemiplimab for recurrent or metastatic cervical cancer
read more
Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas
Meteor Biotech joins South Korea consortium to advance brain organoid commercialisation platform
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Otsuka secures EU approval for Inaqovi combination therapy in acute myeloid leukaemia
read more
Advanced Therapies,Biotech & Pharma Business,Central Nervous System,Drug Discovery & Development
TRIMTECH raises $14M to advance protein degradation therapies for neurodegenerative diseases
read more
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain
Cytomos highlights AuraCyt platform for predictive cell analytics at BIO 2026
read more
Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
Pheno Therapeutics gains FDA clearance for first-in-human multiple sclerosis drug PTD802
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
ViiV Healthcare gains FDA Priority Review for paediatric Tivicay expansion to newborns
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
NICE recommends NHS access to teplizumab for early type 1 diabetes
read more
Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics
InduPro licenses Lonza ADC technology for oncology programmes
read more
Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics
Bionyra launches with $165M Series A to advance immunology biologics pipeline
read more
Advanced Therapies,Clinical & Regulatory,Genomics and sequencing,Therapeutic Areas
Atsena advances gene therapy ATSN-201 into Phase 3 trial for inherited blindness
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
Pierre Fabre wins EU approval for first-line BRAFTOVI regimen in BRAF-mutant colorectal cancer
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
African health leaders launch Imara framework to strengthen sickle cell disease care across Africa
read more
Advanced Therapies
Houdini Bio develops DNA design platform targeting gene therapy silencing
read more
Medical devices
Singapore researchers develop nanosensor for rapid gut biomarker detection
read more
Drug Delivery & Formulation
Lubrizol excipient recognised at CPhI China Pharma Excipients Awards
read more

NICE recommends cemiplimab for recurrent or metastatic cervical cancer

Meteor Biotech joins South Korea consortium to advance brain organoid commercialisation platform

Otsuka secures EU approval for Inaqovi combination therapy in acute myeloid leukaemia

TRIMTECH raises $14M to advance protein degradation therapies for neurodegenerative diseases

Cytomos highlights AuraCyt platform for predictive cell analytics at BIO 2026

Pheno Therapeutics gains FDA clearance for first-in-human multiple sclerosis drug PTD802

ViiV Healthcare gains FDA Priority Review for paediatric Tivicay expansion to newborns

NICE recommends NHS access to teplizumab for early type 1 diabetes

InduPro licenses Lonza ADC technology for oncology programmes

Bionyra launches with $165M Series A to advance immunology biologics pipeline

Atsena advances gene therapy ATSN-201 into Phase 3 trial for inherited blindness

Pierre Fabre wins EU approval for first-line BRAFTOVI regimen in BRAF-mutant colorectal cancer

African health leaders launch Imara framework to strengthen sickle cell disease care across Africa

Houdini Bio develops DNA design platform targeting gene therapy silencing

Singapore researchers develop nanosensor for rapid gut biomarker detection

Lubrizol excipient recognised at CPhI China Pharma Excipients Awards

main menu

recent posts

Seegene launches global million-patient study of syndromic PCR testing

Fonseca Biosciences launches XTORO after FDA clears US commercial manufacturing

Autolomous and Cellular Origins integrate platforms for automated cell therapy manufacturing

get connected